Teradyne Stock Sold by ARK Invest as Wood Rotates Portfolio

What happened

On April 9, ARK Invest's exchange-traded funds executed a series of portfolio transactions, including the sale of Teradyne shares. At the same time, ARK's Innovation ETF (ARKK) and Genomic Revolution ETF (ARKG) purchased 32,767 shares of GeneDx Holdings for $1.97 million, taking advantage of an 8.5% price decline. The firm also increased exposure to Tesla and recently completed a $240 million investment in OpenAI, spread across three flagship ETFs (ARKK, ARKW, and ARKF). OpenAI represents approximately 3% of each fund's allocation following its $122 billion funding round at an $852 billion valuation on March 31.

Why it matters

For Teradyne investors, this sale signals ARK's shifting conviction away from the semiconductor testing equipment maker toward other disruptive technology plays. ARK Invest, known for concentrated positions in high-growth innovation stocks, manages approximately $6.1 billion in its flagship Innovation ETF alone, making its portfolio moves closely watched by retail investors. The rotation suggests ARK sees stronger near-term opportunities in AI infrastructure (through OpenAI), genomics (GeneDx), and electric vehicles (Tesla) rather than Teradyne's chip testing business. While ARK's trades don't necessarily reflect fundamental problems at Teradyne, they do indicate changing priorities within the disruptive innovation investment thesis.

Bigger picture

The portfolio adjustments reflect broader themes in technology investing. ARK's increased focus on generative AI through the OpenAI stake—now held across three ETFs representing different innovation themes—signals conviction that artificial intelligence will be central to future economic value creation. The firm believes agentic AI will lower barriers to entrepreneurship and transform multiple sectors. Meanwhile, semiconductor-related holdings face ongoing volatility as markets weigh AI infrastructure demand against cyclical concerns. GeneDx's addition, despite recent analyst downgrades, demonstrates ARK's willingness to buy quality names during temporary weakness. The moves come as ARK's flagship funds have delivered mixed performance, with ARKK up 65% over 12 months but down amid February's software stock sell-off.

What to watch

Investors should monitor whether other growth-focused funds follow ARK's lead in reducing semiconductor equipment exposure. For Teradyne specifically, watch quarterly results and forward guidance to assess whether fundamental business trends support or contradict ARK's decision. Additionally, observe how ARK's ETFs perform relative to benchmarks now that they hold an illiquid private asset (OpenAI), which creates valuation and redemption complexities. Broader market sentiment toward high-beta technology stocks will likely influence both Teradyne's performance and ARK's future trading activity. Finally, track whether ARK continues accumulating AI infrastructure plays or rotates back toward testing equipment if semiconductor capital spending accelerates.

This article was generated by Quantli AI using publicly available news sources.